MAA Intelligence

org.medicalaialliance/intelligence · v1.0.0 · health-and-science

MAA Intelligence is healthy: it completed an MCP handshake in 1846 ms and exposes 5 tools.

Korean listed medical AI, biotech and device companies linked to MFDS and FDA regulatory records.

Endpoint: https://medicalaialliance.org/api/mcp (streamable-http)

Repository · Website · JSON · Add to my inventory

Facts

Users (last 30 days)0
HandshakeHealthy
Auth neededNone
Tool count5
Latency1846 ms
Last checked (UTC)2026-10-15T13:05:15.762Z

Health history

Checked (UTC)StatusLatencyError
2026-10-15T13:05:15.762ZHealthy1846

Tools (5)

search_companiesSearch Korean listed medical AI, biotech, medical device, pharma and healthcare infrastructure companies. Use this to find companies by name, business keyword, sector, or stock exchange. Returns a summary line per company. Call get_company afterwards for full detail on a specific one.
get_companyFull profile of one company: business overview, products, R&D, financials for the last three years, a breakdown of its regulatory record (MFDS device and drug approvals, clinical trial authorisations, Innovative Medical Device and Orphan Drug designations, US FDA 510(k) clearances and FDA drug appro
get_stock_quoteLive stock quote for one indexed company: price (KRW), daily change, market cap, PER, PBR, 52-week range. Real-time market data — call again for current values; do not treat a quoted price as durable.
search_approvalsSearch regulatory records across all indexed companies. Sources: Korea MFDS (device approvals, drug approvals, clinical trial authorisations, Innovative Medical Device designations, Orphan Drug designations) and the US FDA (510(k)). Use agency='MFDS_INNO' for Innovative Medical Device designations —
industry_overviewAggregate view of the Korean medical AI and biotech sector as indexed by MAA: company counts by sector, total regulatory records by source, and measured AI visibility (how well these companies' own websites can be read by AI systems). Use this for questions about the sector as a whole rather than on